Novelix Pharmaceuticals Ltd share price logo

Novelix Pharmaceuticals Ltd

BSE: 536565

Small Cap

Pharma Sector

₹81.99

+2.11

(+2.64%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Novelix Pharmaceuticals shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+11%

Searches for Novelix Pharmaceuticals on INDmoney have increased by 11% over the last 30 days.

Key Events for Novelix Pharmaceuticals

Last Dividend Declared

₹0.30 per share, declared on 23/07/2012

View Dividend History

Novelix Pharmaceuticals Stock Performance

as on September 16, 2026 at 7:27 pm IST

  • Day's Low

    ₹76.00
    ₹81.99
    downward going graph

    7.31%

    Downside

  • 52 Week's Low

    52 Week's High

    ₹38.00
    ₹92.00
    downward going graph

    53.65%

    Downside

    12.21%

    Upside

    downward going graph

Novelix Pharmaceuticals share price movements today

Previous Close
₹79.88
Open
₹81.99
Volume
11.65K
Upper Circuit
₹83.87
Lower Circuit
₹75.89
Day's Low - High
₹76.00 - ₹81.99
52 Week Low - High
₹38.00 - ₹92.00

Novelix Pharmaceuticals Historical Returns

1 Month Return
+ 8.96 %
3 Month Return
-10.05 %
1 Year Return
+ 99.7 %
3 Year Return
+ 732.95 %
5 Year Return
+ 967.91 %

Novelix Pharmaceuticals Fundamentals

as on September 16, 2026 at 1:57 pm IST

Market Cap

₹227.42 Cr

Return on Equity (ROE)

0.56

PE Ratio (TTM)

41.44

Return on capital employed (ROCE)

0.84

Industry PE ratio

51.81

Beta (LTM)

0.47

P/B Ratio

1.51

Dividend Yield

0

PEG Ratio

32.13

Quarterly Earnings Growth YOY

972.73

EPS (TTM)

0

Book Value

0

Novelix Pharmaceuticals Stock Valuation

as on September 16, 2026 at 1:57 pm IST

Novelix Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-152.86x)

June 6, 2023

Today (41.44x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (1894.00x)

June 24, 2024

LowHigh

Today’s Price to Earnings Ratio: 41.44x

Novelix Pharmaceuticals Technical Analysis

Track how Novelix Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish2
Bullish8
Neutral5

Oscillators

Name

Value

Action

MACD level (12,26)
0.22
Bearish
CCI (20)
35.09
Neutral
RSI (14)
76.07
Bearish
Momentum (10)
0
Neutral
ADI (14)
63.38
Neutral
Ultimate Oscillator (7,14,28)
100
Bullish

Moving Averages

Name

Value

Action

SMA (20)
81.99
Neutral
EMA (20)
81.89
Bullish
VWMA (20)
81.99
Neutral
SMA (50)
80.67
Bullish
EMA (50)
81.07
Bullish
SMA (200)
77.62
Bullish
EMA (200)
78.82
Bullish
KAMA (200)
81.9
Bullish
DEMA (200)
79.96
Bullish

Novelix Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novelix Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Novelix Pharmaceuticals Ltd image
Novelix Pharmaceuticals Ltd
NA227.42193.58%0.00-130
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Novelix Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
0.93
0.5
0.84
0.6
3.96
5.3
20.86
22.35
36.36
48.4
25.19
36.91
Other Income
0.05
0.09
0.13
0.1
-0.08
-
-
-
0.03
-
-
-
Total Income
0.98
0.58
0.97
0.7
3.87
5.3
20.86
22.35
36.39
48.4
25.19
36.92
Expenses
1.03
0.61
0.69
1.04
3.74
5.17
20.63
22.17
35.66
47.09
23.91
35.61
Operating Profit
-0.1
-0.11
0.15
-0.44
0.22
0.13
0.23
0.18
0.7
1.31
1.28
1.3
Operating Profit Margin %
-10.75%
-22%
17.86%
-73.33%
5.56%
2.45%
1.1%
0.81%
1.93%
2.71%
5.08%
3.52%
Profit Before Interest, Tax and Depreciation
-0.06
-0.02
0.28
-0.34
0.14
0.13
0.23
0.18
0.73
1.31
1.28
1.3
Interest
-
-
-
-
-
-
-
-
-
-
-
0.12
Depreciation
0.01
0.01
0.01
-
-
-
0.02
0.01
0.01
0.03
0.05
0.07
Profit Before Tax
-0.07
-0.03
0.27
-0.34
0.14
0.13
0.21
0.17
0.72
1.28
1.23
1.11
Tax Paid
-
-
-
0.01
-
-0.02
0.03
0.07
0.19
0.28
0.32
-0.06
Profit After Tax
-0.07
-0.03
0.28
-0.35
0.13
0.15
0.18
0.11
0.53
1
0.91
1.18
Total Net profit including share of profit / Loss from associate company
-0.07
-0.03
0.28
-0.35
0.13
0.15
0.18
0.11
0.53
1
0.91
1.18
EPS
-0.08
-0.04
0.34
-0.43
0.16
0.15
0.18
0.09
0.37
0.58
0.43
0.49
Actual EPS
-0.08
-0.04
0.34
-0.43
0.16
0.15
0.18
0.09
0.37
0.58
0.43
0.49
Adjusted EPS
-0.08
-0.04
0.34
-0.43
0.16
0.15
0.18
0.09
0.37
0.58
0.43
0.49
Diluted EPS
-0.08
-0.04
0.34
-0.43
0.16
0.16
0.2
0.11
0.49
0.85
0.32
0.49

Novelix Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Sales
10.5
10.46
10.24
9.24
8.61
Other Income
0.21
0.38
0.6
0.34
0.64
Total Income
10.71
10.84
10.85
9.59
9.25
Expenses
10.52
10.62
10.75
13.06
11.18
Operating Profit
-0.02
-0.16
-0.51
-3.82
-2.57
Operating Profit Margin %
-0.19%
-1.53%
-4.98%
-41.34%
-29.85%
Profit Before Interest, Tax and Depreciation
0.19
0.22
0.09
-3.48
-1.93
Interest
0.16
0.13
0.11
0.06
-
Depreciation
0.24
0.21
0.19
0.21
0.1
Profit Before Tax
-0.21
-0.12
-0.21
-3.75
-2.03
Tax Paid
0.14
0.03
0.05
0.01
-0.01
Profit After Tax
-0.35
-0.15
-0.26
-3.76
-2.03
Total Net profit including share of profit / Loss from associate company
-0.35
-0.15
-0.26
-3.76
-2.03
EPS
-0.48
-0.3
-0.35
-4.62
-2.22
Actual EPS
-0.48
-0.3
-0.35
-4.62
-2.22
Adjusted EPS
-0.48
-0.3
-0.35
-4.62
-2.22
Diluted EPS
-0.48
-0.3
-0.35
-4.62
-2.22

Novelix Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Net Cash from Operating Activities
2.05
-1.82
0.37
-0.53
0.63
1.59
1.59
Cash Flow from Investing Activities
-1.06
0.21
-0.63
0.42
0.46
0.13
-0.76
Cash Flow from Financing Activities
0.22
0.77
0.02
-0.05
-0.16
-0.77
-
Net Cash Flow
1.22
-0.84
-0.24
-0.15
0.92
0.96
0.83

Novelix Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Aug 2025
Sep 2025
Nov 2025
Dec 2025
Jan 2026
Feb 2026
Mar 2026
Jun 2026
Jul 2026
Promoters
66.92%
66.92%
66.54%
66.56%
66.56%
66.56%
52.75%
53.33%
54.82%
54.82%
51.98%
50.8%
46.51%
49.43%
50.57%
54.29%
Public
33.08%
33.08%
33.46%
33.44%
33.44%
33.44%
47.25%
46.67%
45.18%
45.18%
48.02%
49.2%
53.49%
50.57%
49.43%
45.71%
Total Outstanding Shares
81,00,000
81,00,000
99,50,000
99,50,000
99,50,000
99,50,000
1,29,35,000
1,44,80,000
1,61,41,000
1,61,41,000
1,72,15,000
1,76,15,000
1,99,35,000
2,10,85,000
2,38,95,000
2,84,70,000
Total Shareholders
2,621
2,635
2,569
2,533
2,502
2,484
2,408
2,754
2,770
2,770
2,994
2,997
3,029
2,975
3,118
3,127

Novelix Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Novelix Pharmaceuticals.

  • Novelix Pharmaceuticals Ltd Earnings Results

    Novelix Pharmaceuticals Ltd’s net profit fell -140.63% since last year same period to ₹0.13Cr in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -85.71% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Novelix Pharmaceuticals Ltd Dividends July,2012

    In the quarter ending June 2012, Novelix Pharmaceuticals Ltd has declared dividend of ₹0.30 per share on 23 Jul 2012 - translating a dividend yield of 0.77%.

    Read More about Dividends

Insights on Novelix Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, Novelix Pharma. stock has moved up by 99.7%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 50.57% to 54.29% in Jul 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Arvaya Healthcare Ltd has given 295.3% return, outperforming this stock by 195.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 49.43% to 45.71% in Jul 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -0.07 Cr → -0.13 Cr (in ₹), with an average decrease of 85.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.43 Cr → 1.3 Cr (in ₹), with an average decrease of 9.1% per quarter

About Novelix Pharmaceuticals Ltd

Trimurthi Drugs & Pharmaceuticals Ltd was established in December 1994 and initially engaged in finance and investments. However, due to the volatile market conditions they stopped their operations and carried out diversification into pharmaceuticals and drugs. In 2009 the company was awarded NSEN ISO 9001:2008/ ISO 9001:2008 for marketing and distribution of pharmaceutical products. During 2011 Trimurthi Drugs & Pharmaceuticals Ltd opened their first Pharmacy Retail Outlet in Himayath Nagar and a second retail outlet in Inderbagh Sultan Bazar, Hyderabad. Over the coming years the company plans to expand their business all over India by setting up a marketing network. The company also hopes to open 50 more retail outlets and commence with Pharmacy and Medical Malls based in Hyderabad and Secunderabad providing medical services and products.

Revenue: ₹1.24Cr as on September 2022 (Q2 FY23)
Net Profit: ₹0.15Cr as on September 2022 (Q2 FY23)
OrganisationNovelix Pharmaceuticals Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Novelix Pharmaceuticals share price today?

Novelix Pharmaceuticals share price today stands at ₹81.99 as on . Novelix Pharmaceuticals share today touched a day high of ₹81.99 and a low of ₹76.

What is the 52 week high and 52 week low range for Novelix Pharmaceuticals share?

Novelix Pharmaceuticals touched a 52 week high of ₹92 and a 52 week low of ₹38. Novelix Pharmaceuticals share price today i.e. is trending at ₹81.99, which is -10.88% down from its 52 week high and 115.76% up from its 52 week low.

What is Novelix Pharmaceuticals's market capitalisation today?

Novelix Pharmaceuticals market capitalisation is ₹227.42 Cr as on .

How to buy Novelix Pharmaceuticals shares?

To buy Novelix Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 536565 or Novelix Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Novelix Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Novelix Pharmaceuticals trading volume today?

Novelix Pharmaceuticals trading volume is 11.65K as on . This means that 11.65K shares of Novelix Pharmaceuticals were bought and sold on the stock market during today's trading session.